Open AccessWLS inhibits melanoma cell proliferation through the β‐catenin signalling pathway and induces spontaneous metastasis
Author(s) -
Yang PeiTzu,
Anastas Jamie N.,
Toroni Rachel A.,
Shinohara Michi M.,
Goodson Jamie M.,
Bosserhoff Anja K.,
Chien Andy J.,
Moon Randall T.
Publication year - 2012
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.1002/emmm.201201486
Subject(s) - wnt signaling pathway , melanoma , catenin , cancer research , cell growth , metastasis , biology , microbiology and biotechnology , beta catenin , cell culture , cell , chemistry , signal transduction , cancer , genetics
Abstract Elevated levels of nuclear β‐catenin are associated with higher rates of survival in patients with melanoma, raising questions as to how ß‐catenin is regulated in this context. In the present study, we investigated the formal possibility that the secretion of WNT ligands that stabilize ß‐catenin may be regulated in melanoma and thus contributes to differences in ß‐catenin levels. We find that WLS, a conserved transmembrane protein necessary for WNT secretion, is decreased in both melanoma cell lines and in patient tumours relative to skin and to benign nevi. Unexpectedly, reducing endogenous WLS with shRNAs in human melanoma cell lines promotes spontaneous lung metastasis in xenografts in mice and promotes cell proliferation in vitro . Conversely, overexpression of WLS inhibits cell proliferation in vitro . Activating β‐catenin downstream of WNT secretion blocks the increased cell migration and proliferation observed in the presence of WLS shRNAs, while inhibiting WNT signalling rescues the growth defects induced by excess WLS. These data suggest that WLS functions as a negative regulator of melanoma proliferation and spontaneous metastasis by activating WNT/β‐catenin signalling.